The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Clinical observation of recombinant human interferon α 2b ointment for the treatment of genital herpes simplex and condyloma acuminatum
Author(s): 
Pages: 169-170
Year: Issue:  3
Journal: JOURNAL OF CLINICAL DERMATOLOGY

Keyword:  重组人干扰素α2b生殖器疱疹尖锐湿疣;
Abstract: 对60例生殖器疱疹和40例尖锐湿疣患者局部应用基因重组人干扰素α2b软膏进行随机双盲对照试验观察.结果显示:前者治疗1周临床痊愈率为79.41%,有效率为82.35%;后者治疗8周临床痊愈率为26.3%,有效率为42.1%,均明显优于基质对照组.治疗中未见不良反应.对生殖器疱疹和皮损少和小的尖锐湿疣患者,使用重组人干扰素α2b软膏简便、有效和安全.
Related Articles
No related articles found